ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. [electronic resource]
Producer: 20140808Description: 2152-60 p. digitalISSN:- 1527-3350
- Adult
- Anemia, Hemolytic -- chemically induced
- Antiviral Agents -- administration & dosage
- Clinical Trials, Phase IV as Topic
- Drug Therapy, Combination
- Female
- Hepatitis C -- complications
- Humans
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Pyrophosphatases -- deficiency
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- administration & dosage
- Retrospective Studies
- Ribavirin -- administration & dosage
- Inosine Triphosphatase
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.